Literature DB >> 5440518

Haemodynamic studies in hypertensive patients treated by oral proranolol.

B N Prichard, E Shinebourne, J Fleming, J Hamer.   

Abstract

Haemodynamic studies have been performed in 9 patients whose blood pressures had been satisfactorily controlled with oral propranolol for 7 to 29 months. A postural drop of blood pressure or a fall of blood pressure on exercise did not occur. Pulse rate and cardiac output were below normal at rest and on exercise; peripheral resistance was high. The results are similar to those obtained in a comparable group of hypertensives after acute administration of propranolol. These findings are discussed in relation to the mode of action of propranolol in hypertension.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5440518      PMCID: PMC487309          DOI: 10.1136/hrt.32.2.236

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  5 in total

1.  Effect of walking on blood-pressure in systemic hypertension.

Authors:  J Hamer; J Fleming; E Shinebourne
Journal:  Lancet       Date:  1967-07-15       Impact factor: 79.321

2.  Evidence that the effect of beta-adrenergic blockade on the haemodynamic response of hypertensive patients to exercise is not solely rate-dependent.

Authors:  E Shinebourne
Journal:  Cardiovasc Res       Date:  1969-01       Impact factor: 10.787

3.  Immediate hemodynamic effects of beta-adrenergic blockade with propranolol in normotensive and hypertensive man.

Authors:  M Ulrych; E D Frohlich; H P Dustan; I H Page
Journal:  Circulation       Date:  1968-03       Impact factor: 29.690

4.  The paradox of beta-adrenergic blockade in hypertension.

Authors:  E D Frohlich; R C Tarazi; H P Dustan; I H Page
Journal:  Circulation       Date:  1968-03       Impact factor: 29.690

5.  USE OF PROPRANOLOL (INDERAL) IN TREATMENT OF HYPERTENSION.

Authors:  B N PRICHARD; P M GILLAM
Journal:  Br Med J       Date:  1964-09-19
  5 in total
  9 in total

Review 1.  The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.

Authors:  B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

2.  Blockade of cardiac and renal beta-receptors by low dose propranolol in normal subjects. Clues to its antihypertensive effect.

Authors:  R Davies; T G Pickering; A Morganti; M Wilson; J H Laragh
Journal:  Br Heart J       Date:  1979-03

3.  Long term treatment of moderate hypertension with penbutolol (Hoe 893d). I. Effects on blood pressure, pulse rate, catecholamines in blood and urine, plasma renin activity and urinary aldosterone under basal conditions and following exercise.

Authors:  B G Hansson; B Hökfelt
Journal:  Eur J Clin Pharmacol       Date:  1975-10-10       Impact factor: 2.953

4.  Direct assessment of cardiac function.

Authors:  J Hamer
Journal:  Br J Clin Pharmacol       Date:  1978-07       Impact factor: 4.335

Review 5.  Pharmacodynamic properties of beta-adrenergic receptor blocking drugs in man.

Authors:  D G Gibson
Journal:  Drugs       Date:  1974       Impact factor: 9.546

Review 6.  Beta-adrenergic receptor blocking drugs in hypertension.

Authors:  F O Simpson
Journal:  Drugs       Date:  1974       Impact factor: 9.546

7.  Combined alpha- and beta-adrenoceptor blockade with labetalol in hypertension.

Authors:  M H Frick; P Pörsti
Journal:  Br Med J       Date:  1976-05-01

8.  Hypotensive effect of oxprenolol in mild to moderate hypertension: a multicentre controlled study.

Authors:  M Motolese; G Muiesan; A Colombi
Journal:  Eur J Clin Pharmacol       Date:  1975       Impact factor: 2.953

Review 9.  Uses of beta-adrenoceptor blocking drugs.

Authors:  B N Prichard; D G McDevitt; R G Shanks
Journal:  J R Coll Physicians Lond       Date:  1976-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.